Ernexa Therapeutics Inc. (ERNA) Share-based Compensation (2010 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Share-based Compensation came in at $309000.0 in Q1 2026, down 38.45% YoY from $502000.0 in Q1 2025, and up 130.23% on a QoQ basis from -$1.0 million in Q4 2025.
Ernexa Therapeutics Inc. (ERNA) Share-based Compensation (2010 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 17 years of Share-based Compensation data on file, last reported at $309000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 38.45% year-over-year to $309000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52000.0 (down 102.99% YoY) and the FY2025 annual result came in at $1.4 million, down 39.13% from the prior year.
- Share-based Compensation improved to $309000.0 in Q1 2026, from -$1.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.9 million in Q4 2022 to a low of -$1.0 million in Q4 2025.
- A 5-year average of $510588.2 and a median of $405000.0 in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2024 — Share-based Compensation soared 148.48% — and 2025, when it sank 349.27%.
- Tracing ERNA's Share-based Compensation over 5 years: stood at $2.9 million in 2022, then slumped by 94.37% to $165000.0 in 2023, then soared by 148.48% to $410000.0 in 2024, then tumbled by 349.27% to -$1.0 million in 2025, then jumped by 130.23% to $309000.0 in 2026.
- The last three Share-based Compensation figures came in at $309000.0 (Q1 2026), -$1.0 million (Q4 2025), and $293000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 320,000.00 |
| Jun 30, 2026 | 320,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | 293,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 368,000.00 |
| Jun 30, 2025 | 368,000.00 |
| Mar 31, 2025 | 502,000.00 |
| Mar 31, 2025 | 502,000.00 |
| Dec 31, 2024 | 410,000.00 |
| Dec 31, 2024 | 410,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 423,000.00 |
| Jun 30, 2024 | 423,000.00 |
| Mar 31, 2024 | 282,000.00 |
| Mar 31, 2024 | 282,000.00 |